D. Gibson

1.0k total citations
10 papers, 454 citations indexed

About

D. Gibson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, D. Gibson has authored 10 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in D. Gibson's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Renal cell carcinoma treatment (3 papers). D. Gibson is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Renal cell carcinoma treatment (3 papers). D. Gibson collaborates with scholars based in United States, Australia and United Kingdom. D. Gibson's co-authors include Afshin Dowlati, Herbert I. Hurwitz, Elmar M. Merkle, Jeffrey P. Hodge, Shermini Saini, A. Benjamin Suttle, S. Savage, Lini Pandite, Krista Kinneer and Shaji Kumar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

D. Gibson

10 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Gibson United States	7	250	234	207	87	76	10	454
S. Savage United States	7	261 1.0×	297 1.3×	258 1.2×	47 0.5×	112 1.5×	8	493
James A. Onori United States	4	224 0.9×	236 1.0×	254 1.2×	43 0.5×	123 1.6×	5	500
Amogh Boloor United States	5	194 0.8×	219 0.9×	247 1.2×	35 0.4×	89 1.2×	5	500
Teresa M. Hopper United States	4	204 0.8×	231 1.0×	243 1.2×	35 0.4×	101 1.3×	6	486
Marilyn Mulay United States	11	365 1.5×	250 1.1×	243 1.2×	37 0.4×	104 1.4×	17	644
Sönke Korfee Germany	4	306 1.2×	273 1.2×	359 1.7×	72 0.8×	154 2.0×	8	720
Herb Kotz United States	11	325 1.3×	130 0.6×	148 0.7×	55 0.6×	86 1.1×	23	494
Lawrence Garbo United States	15	427 1.7×	188 0.8×	311 1.5×	71 0.8×	84 1.1×	35	741
Ursula Vogl Austria	9	397 1.6×	417 1.8×	341 1.6×	62 0.7×	171 2.3×	20	878
Markus Faghih Germany	2	285 1.1×	257 1.1×	357 1.7×	72 0.8×	152 2.0×	3	705

Countries citing papers authored by D. Gibson

Since Specialization

Citations

This map shows the geographic impact of D. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gibson more than expected).

Fields of papers citing papers by D. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gibson. The network helps show where D. Gibson may publish in the future.

Co-authorship network of co-authors of D. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gibson. A scholar is included among the top collaborators of D. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gibson. D. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kumar, Shaji, Magdalini Migkou, Manisha Bhutani, et al.. (2020). Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 136(Supplement 1). 26–27. 51 indexed citations

Kieran, Mark W., Kenneth J. Cohen, François Doz, et al.. (2014). Complete radiographic responses in pediatric patients with BRAF^V600-positive tumors including high-grade gliomas: Preliminary results of an ongoing phase 1/2a safety and pharmacokinetics (PK) study of dabrafenib.. Journal of Clinical Oncology. 32(15_suppl). 10056–10056. 4 indexed citations

Plummer, Ruth, Ayman Madi, Heike Richly, et al.. (2012). A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(1). 93–101. 25 indexed citations

Soria, Jean‐Charles, Hui Gan, Hendrik‐Tobias Arkenau, et al.. (2012). Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). 3000–3000. 12 indexed citations

Soria, Jean‐Charles, Ruth Plummer, Malcolm Ranson, et al.. (2012). 610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma. European Journal of Cancer. 48. 188–188. 7 indexed citations

Gibson, D.. (2011). Ambiguities in the making of an African Medicine: clinical trials of Sutherlandia frutescens (L.) R.Br (Lessertia frutescens).. 15(1). 124–137. 8 indexed citations

Fasolo, Angelica, C. Sessa, Luca Viganò, et al.. (2010). Phase Ib clinical and pharmacological study of multiple schedules of pazopanib (P) and epirubicin (EPI) in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). 3047–3047. 1 indexed citations

Hurwitz, Herbert I., Afshin Dowlati, Shermini Saini, et al.. (2009). Phase I Trial of Pazopanib in Patients with Advanced Cancer. Clinical Cancer Research. 15(12). 4220–4227. 333 indexed citations

Jones, Suzanne F., Afshin Dowlati, Benjamin Suttle, et al.. (2008). Phase I study of the safety, tolerability, and pharmacokinetics (PK) of weekly paclitaxel administered in combination with pazopanib (GW786034). Journal of Clinical Oncology. 26(15_suppl). 3552–3552. 7 indexed citations

10.

Suttle, Benjamin, Afshin Dowlati, Antoinette R. Tan, et al.. (2007). Phase I study of the safety and pharmacokinetics (PK) of paclitaxel or paclitaxel with carboplatin administered in combination with pazopanib (GW786034). Journal of Clinical Oncology. 25(18_suppl). 14118–14118. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact